Today: 28 December 2025
Subscribe

Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Stock (NASDAQ: BIIB) News and Forecasts for Dec. 20, 2025: RBC’s $210 Target, Leqembi Catalysts, and What Investors Are Watching

Biogen Inc. stock (NASDAQ: BIIB) is ending the week on a stronger note after a sharp, high-volume move on Friday’s session—an attention-grabbing setup heading into late December when liquidity often thins and headlines can move shares quickly. As of Saturday,
20 December 2025
·····
KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation Stock (KLAC): Today’s News, Analyst Forecasts, and 2026 Outlook as AI Drives Chip Equipment Spending (Dec. 20, 2025)

KLA Corporation (NASDAQ: KLAC) heads into the Dec. 20, 2025 weekend with its stock sitting near recent highs after a volatile mid-December stretch that featured a major analyst upgrade, multiple price-target increases, and fresh industry forecasts projecting another leg of
20 December 2025
····
Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

Amicus Therapeutics (FOLD) Stock Today: BioMarin’s $4.8B Cash Buyout at $14.50 Resets the Outlook (Dec. 20, 2025)

December 20, 2025 — Amicus Therapeutics, Inc. (NASDAQ: FOLD) has abruptly shifted from a “rare-disease growth story” to a merger-arbitrage stock after BioMarin Pharmaceutical announced a definitive, all-cash acquisition valued at roughly $4.8 billion. The headline number for shareholders: $14.50
20 December 2025
······
Uber Stock (NYSE: UBER) News on Dec. 20, 2025: Uber One Lawsuit, Robotaxi Momentum, and Analyst Forecasts Heading Into 2026

Uber Stock (NYSE: UBER) News on Dec. 20, 2025: Uber One Lawsuit, Robotaxi Momentum, and Analyst Forecasts Heading Into 2026

Uber Technologies, Inc. (NYSE: UBER) is ending 2025 with a split-screen narrative investors can’t ignore: strong operational momentum and expanding autonomous-vehicle partnerships on one side, and a fresh wave of regulatory/legal pressure tied to Uber One subscriptions on the other.
20 December 2025
·····
American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

American Express (AXP) Stock News, Forecasts and Analysis for Dec. 20, 2025: Dividend Update, Holiday-Spend Momentum, and What Investors Are Watching Next

Dec. 20, 2025 — American Express Company (NYSE: AXP) is ending the year near fresh highs as investors weigh two competing narratives: a resilient premium-spending backdrop that continues to support card volumes and fee growth, and a late-2025 policy and
20 December 2025
····
Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Philip Morris International (PM) Stock News Today: Dividend, FDA Catalysts, and Wall Street Forecasts as of Dec. 20, 2025

Updated: December 20, 2025 — Philip Morris International Inc. (NYSE: PM) stock is ending the week in the spotlight as investors balance a resilient dividend story with a fast-moving U.S. “smoke-free” growth narrative built around ZYN nicotine pouches and the
20 December 2025
·····
Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Gilead Sciences Stock (NASDAQ: GILD) Today: TrumpRx Drug-Pricing Deal, HIV Pipeline Momentum, and Wall Street Forecasts (Dec. 20, 2025)

Updated: December 20, 2025 Gilead Sciences, Inc. (NASDAQ: GILD) heads into the weekend with fresh policy headlines, a high-profile pricing agreement tied to the Trump administration’s TrumpRx initiative, and renewed attention on the company’s next-generation HIV portfolio. The combination has
20 December 2025
·····
1 … 202 203 204 205 206 … 1,548
Go toTop